Navigation Links
Sinovac Receives SFDA Approval to Commence Clinical Trials for Inactivated Enterovirus Type 71 Vaccine
Date:12/28/2010

BEIJING, Dec. 28, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease (HFMD). According to the approval document, Sinovac is required to conduct each phase of the human clinical trials in accordance with SFDA requirements, to conduct studies to assess safety and immunogenicity in the phase I and II clinical trials, and to conduct efficacy study in the phase III clinical trial. Sinovac filed in late December 2009 with the SFDA the application to commence human clinical trials for its inactivated EV71 vaccine.

Dr. Weidong Yin, Chairman, President & CEO, stated, "We are very pleased to advance our near term vaccine development pipeline with the approval from the SFDA to commence clinical trials for our internally developed EV 71 vaccine. Currently, there is no vaccine available worldwide for this disease. We had no precedent to go by during the development, so we had to start with the basic research on this vaccine. Moreover, our R&D people has successfully completed pre-clinical research and made significant breakthroughs during the development. We will move forward with our research and development of vaccines with the objective to supply high quality vaccine products to children worldwide as soon as possible and to contribute to the prevention and control of HFMD."As previously announced, the Company began preclinical research in 2008 for its independently developed EV 71 vaccine.  The animal model, built by researchers at Sydney University, showed cross protection and demonstrated that the vaccine is effective in animals. In addition, Sinovac has already filed five patent applications cove
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
2. Sinovac Selected by Beijing CDC to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
3. Sinovac Receives Drug Registration Certificate from Hong Kong Department of Health for Seasonal Flu Vaccine Anflu(R)
4. Sinovac to Host Conference Call to Report Second Quarter 2010 Financial Results
5. Sinovac Holds 2010 Annual Meeting of Shareholders
6. Sinovac Schedules 2010 Annual Meeting of Shareholders
7. Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)
8. Sinovac Announces Plan to Launch Offering of Common Shares
9. Sinovac Announces Recent Developments
10. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
11. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... YORK , Sept. 2, 2014 Reportlinker.com ... in its catalogue: Asia - Pacific ... http://www.reportlinker.com/p02353212/Asia---Pacific-Minimally-Invasive-Surgery-Spinal-Device-Market.html The growth rate of ... spinal device market will remain at double-digit levels throughout ... surgeries as the future of this field. The ...
(Date:9/2/2014)... -- Perrigo Company plc, a public limited company incorporated under ... Company "), today announced that it is offering to exchange ... Senior Notes due 2016 (the " 2016 Exchange Notes "), ... " 2018 Exchange Notes "), $800,000,000 of its new 4.00% ... and $400,00,000 of its new 5.30% Senior Notes due 2043 ...
(Date:9/2/2014)... , Sept. 2, 2014  Ameritox SM , ... "A Deadly Trend: Prescription Drugs to Heroin," a research ... to heroin abuse, and examines deadly trends that have ... found here . The report ... of patients prescribed opioids. It examines five trends that ...
Breaking Medicine Technology:Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic 2
... Inc., a pharmaceutical company advancing orally-available antiviral therapeutics to ... President and Chief Executive Officer, will present at the ... 2011 at 3:00 p.m. ET at the Hilton New ... Mr. Moch will give an update on the company,s ...
... Codexis, Inc. (Nasdaq: CDXS ) today announced ... Officer and Senior Vice President, Process Development and Manufacturing, a ... Ph.D., President and Chief Executive Officer. Dr. ... DuPont. He served as Vice President, Research and Development for ...
Cached Medicine Technology:Chimerix to Present at the Citi 2011 Global Health Care Conference 2Chimerix to Present at the Citi 2011 Global Health Care Conference 3Codexis Names David Anton CTO & SVP, Process Development & Manufacturing 2
(Date:9/2/2014)... On August 30, 2014, Harper’s Bazaar ... You Should Wash Your Face .” According to ... population breathes air considered polluted by the World Health ... the skin’s pores destroying its natural oils. These oils ... that may cause cell damage, redness, aging skin ...
(Date:9/2/2014)... patients treated with lumpectomy followed by radiation therapy ... mastectomy, according to a large study conducted by ... and the Cancer Prevention Institute of California. , ... with the disease is the first to directly ... surgical interventions: bilateral mastectomy (the removal of both ...
(Date:9/2/2014)... 2, 2014 In a large population-based study ... that mild cognitive impairment (MCI) occurred twice more ... 2. Interestingly, this strong association was only observed ... participants (66-80 years) the association vanished. This study ... Disease . , The concept of MCI describes ...
(Date:9/2/2014)... within a few days of discharge do so principally because ... in other parts of the health care system, according to ... Annals of Emergency Medicine ( "Return Visits to the ... asked why they did not follow up as an outpatient, ... wait until their scheduled appointment or being instructed to return ...
(Date:9/2/2014)... 02, 2014 The Dream2Walk Foundation along with ... Sept. 14th, 2014 during Spinal Cord Injury Awareness Month featuring ... England, and Chuck Ligon. Linear Automotive will be there hosting ... , Doors open at 2pm. The car show is Pre ... free pass to the concert. There will be trophies for ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 3Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 4Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2
... Is it safe to wait to make a,decision about ... for all the doctor appointments and test results? Or ... Reassuring research,says that men can take the time they ... of Harvard Men,s Health Watch., One study evaluated ...
... and caregivers offers tips to families, friends, caregivers ... ... CHICAGO, Feb. 4 What do you say, what can you ... from a serious,disease? To kick-off National Patient Recognition Week, a week-long,observance ...
... More than half a million women around the world, ... natural family planning methods developed by Georgetown University Medical ... and thousands of others use CycleBeads a visual aid ... fertility to plan or prevent pregnancy. , Now ...
... York Methodist Hospital today announced the start of the ... multi-center clinical trial to explore an investigational treatment that ... suffering with advanced widespread emphysema. The study focuses on ... in the lung for trapped air to escape and ...
... the Stowers Institutes Trainor Lab has demonstrated that it can ... a gene implicated in the abnormality or by inhibiting its ... the Web site of the journal Nature Medicine yesterday, is ... cause of TCS. , The team evaluated how a ...
... Provide Insight ... 50+-year Relationships, MCLEAN, Va., Feb. 4 Sunrise Senior Living,(NYSE: ... services with,more than 450 communities worldwide, shared the results of a ... spent more than,five decades of special Valentine,s Days together., Sunrise ...
Cached Medicine News:Health News:Men Can Take Their Time to Decide on Prostate Cancer Treatment, Reports the Harvard Men's Health Watch 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 3Health News:CycleBeads help women manage their fertility 2Health News:New York Methodist Hospital to study airway bypass treatment for emphysema 2Health News:Trainor Lab prevents rare birth defect by inactivating p53 gene 2Health News:Secrets to Long-Lasting Marriages Revealed in Senior Survey 2Health News:Secrets to Long-Lasting Marriages Revealed in Senior Survey 3
... 3 year warranty Set one of ... for B.I.O. exam!, One touch auto return ... in 4 colors , Solid-State push button ... holder and transformer. , Electro-Magnetic counter-balanced slit ...
3.5v Standard Ophthalmoscope Set with Convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
High-quality eyecare from the preferred name in diagnostic instruments....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: